logo-loader
RNS
Geiger Counter Limited

Monthly Factsheet- July 2026

RNS Number : 0889T
Geiger Counter Ltd
02 September 2026
 

 

NCIM - Geiger Counter Ltd - Fund Page

 

Geiger Counter Limited

(the "Company")

 

Monthly Investor Report 2 September 2026

(All Factsheet data is at 31 July 2026)

 

The full monthly factsheet is now available on the Company's website, and a summary can be found below.

 

NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd

 

 

Enquiries:

 

For the Investment Manager

Craig Cleland

Manulife CQS Investment Management

0207 201 5368

 

For the Company Secretary and Administrator

Summit Fund Services Jersey Limited

Jane De Barros /Katie De La Cour

01534 825200

 

-----------------------------------------------------------------------

 

 

Fund Description

 

The objective of Geiger Counter Limited is to provide investors with the potential for capital growth through investment primarily in the securities of companies involved in the exploration, development and production of energy, predominantly within the uranium industry. Up to 30% of the value of the Company's investment portfolio may be invested in other resource-related companies from outside the energy sector.

 

Portfolio Managers

 

Diana Racanelli and Craig Bethune

 

 

Key Advantages for the Investor

 

·        Access to mining assets in the uranium sector

·        May benefit from embedded subscription share

·        Low correlation to major asset classes

 

Key Fund Facts1

 

Total Gross Assets 

£81.7m

Reference Currency 

GBP 

Ordinary Shares: 

118,010,966

  Net Asset Value 

61.23p 

  Mid-Market Price       

56.30p 

Net gearing4 

13.00% 

Discount 

(8.05%) 

 

 

Ordinary Share and NAV Performance2

 

 

One Month 

Three Months 

One Year 

Three Years 

Five Years 

 

(%) 

(%) 

(%) 

(%) 

(%) 

NAV 

(9.30)

(35.51)

15.99

34.93

68.08

Share Price 

(12.98)

(19.57)

19.03

45.29

56.39

 

 

Commentary3

 

The Company's NAV declined by 9.30% in July, in line with uranium equities and uranium-based ETFs. July delivered a strong fundamental backdrop for global uranium policy, following a highly progressive policymaking environment in June. Uranium continues to benefit from energy security, reshoring and carbon-free power themes, while also serving as a critical enabler of baseload power capacity in an era of rising electricity demand. The nuclear macro narrative reached new highs: Australia and India signed a landmark supply deal, BNEF forecasts 44% growth in global nuclear capacity, China approved $25Bn worth of new reactors, Brazil plans to make nuclear accessible to private markets, Trump hosted nuclear CEOs in the Oval Office as part of the administration's AI-nuclear initiative, now also including Oklo and X-Energy.

 

Yet, this month presented a striking divergence between uranium's strengthening fundamental story, rising energy prices on the back of the Iran and Ukraine conflict, and the performance of uranium equities, which were impacted mostly by market noise. The market remains concerned about the hyper-scalers' ability to fund all the capex needed for AI with debt, and the backdrop of rising interest rates adds to funding concerns. Uranium equities closely followed the AI power trade, and when tech stocks pulled back in July, the thematic unwind extended into nuclear trades. This is a recurring theme amongst thematic investment styles: the stronger the macro narrative, the more crowded the trade, and the more volatile equities become in the face of sentiment shifts rather than relying on fundamentals.

 

Still, record long-term contract prices, sovereigns leading buying activity, and signs of accelerating utility contracting all support ongoing tightness in the uranium market and a constructive medium- term price outlook. The Athabasca Basin remains a critical source of future supply growth, as companies continue to advance projects. Notably, Denison's Phoenix project reached full-scale construction this month. The spot uranium price was up $1.10 to $86.60/lb over the month. The Company's weighting is balanced between producers and developers, with the latter continuing to benefit from uncontracted volumes in a rising long-term uranium price environment.

 

 

Gross Leverage2

(%)

Commitment Leverage3

(%)

Geiger Counter Ltd 

114

114

 

 

CQS (UK) LLP

4th Floor, One Strand, London WC2N 5HR, United Kingdom

T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200

 

CQS (US), LLC

152 West 57th Street, 40th Floor, New York, NY 10019, US

T: +1 212 259 2900 | F: +1 212 259 2699

 

Tavistock Communications

18 St. Swithin's Lane, London EC4N 8AD

T: +44 20 7920 3150 | geigercounter@tavistock.co.uk

 

Sources: 1Summit Fund Services Jersey Limited, as at the last business day of the month indicated at the top of this report. 2Summit Fund Services Jersey Limited/DataStream, as at the last business day of the month indicated at the top of this report, total return performance net of fees and expenses based on bid prices. These include historic returns and past performance is not a reliable indicator of future results. The value of investments can go down as well as up. Please read the important legal notice at the end of this document. 3Market data sourced from Bloomberg unless otherwise stated. The Company may since have exited some or all of the positions detailed in the commentary. 4BMO, UxC, Company data September 2023. 5www.eia.gov. 6Manulife | CQS Investment Management, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 7, 9 and 10 of Delegated Regulation 231/2013. 7Manulife | CQS Investment Management, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9, 10 and 11 of Delegated Regulation 3231/2013.

 

The Company has announced the sixth Subscription Rights Price of 94.26 pence on 1 May 2026. The exercise date for the sixth Subscription Right is expected to be 30 April 2027.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCGIGDCXUGDGLD
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read